Targeting of SEC62 could also be beneficial in RA, since SEC62 has been found to be induced in a human RA synovial tissue study, especially in a patient cohort that is characterized by expansion of FLS and not by predominance of the myeloid/lymphoid compartment before receiving any treatment (59). The gene discussed is SEC62; the disease is rheumatoid arthritis.